These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 10476212)
21. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Wildner O; Morris JC; Vahanian NN; Ford H; Ramsey WJ; Blaese RM Gene Ther; 1999 Jan; 6(1):57-62. PubMed ID: 10341876 [TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model. Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830 [TBL] [Abstract][Full Text] [Related]
23. Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. Stefani AL; Barzon L; Castagliuolo I; Guido M; Pacenti M; Parolin C; Farinati F; Palù G J Hepatol; 2005 May; 42(5):728-35. PubMed ID: 15826723 [TBL] [Abstract][Full Text] [Related]
24. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice. Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837 [TBL] [Abstract][Full Text] [Related]
25. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Wildner O; Morris JC Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625 [TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer. Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111 [TBL] [Abstract][Full Text] [Related]
27. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system. Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204 [TBL] [Abstract][Full Text] [Related]
28. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On. Hu WX; Zeng ZJ; Luo SQ; Chen Q Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787 [TBL] [Abstract][Full Text] [Related]
29. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy. Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278 [TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy. Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323 [TBL] [Abstract][Full Text] [Related]
34. Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir. Wang S; Qi J; Smith M; Link CJ Cancer Gene Ther; 2002 Jan; 9(1):1-8. PubMed ID: 11916238 [TBL] [Abstract][Full Text] [Related]
35. Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase. Wei SJ; Chao Y; Shih YL; Yang DM; Hung YM; Yang WK Gene Ther; 1999 Mar; 6(3):420-31. PubMed ID: 10435092 [TBL] [Abstract][Full Text] [Related]
36. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals. Su H; Lu R; Ding R; Kan YW Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975 [TBL] [Abstract][Full Text] [Related]
37. Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene. Ural AU; Takebe N; Adhikari D; Ercikan-Abali E; Banerjee D; Barakat R; Bertino JR Gynecol Oncol; 2000 Mar; 76(3):305-10. PubMed ID: 10684701 [TBL] [Abstract][Full Text] [Related]
38. HSV-tk gene therapy for human renal cell carcinoma in nude mice. Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775 [TBL] [Abstract][Full Text] [Related]
39. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
40. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells. Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]